FY26FY27FY28

NTA per share (p)
Range (p)

595
583 - 604

626
592 - 644

656
601 - 695

Underlying PBT (£'m)
Range (£'m)

291
288 - 299

311
307 - 323

330
323 - 343

Underlying EPS (p)
Range (p)

28.8
28.5 - 29.6

30.6
30.2 - 31.5

32.5
31.7 - 33.2

DPS (p)
Range (p)

23.0
22.8 - 23.6

24.5
24.2 - 25.2

26.0
25.4 - 26.6

Number of estimates

13

13

13

Last updated on 31 March 2026.

Note: These forecasts exclude analyst estimates which pre-date the publication of British Land's interim results for the six months ending 30 September 2025, which were published on 19 November 2025.

Due to the offer for Life Science REIT Plc under the Takeover Code, estimates from UBS, Morgan Stanley and Panmure Liberum have been excluded from the consensus as connected advisers to British Land and Life Science REIT.

The following analysts publish forecasts for British Land: 
ABN AMRO – ODDO BHF, Barclays, Berenberg, Bernstein, BofA - Merrill Lynch, Citi, Deutsche Numis, Goldman Sachs, Jefferies, JP Morgan, Kempen & Co. NV, Kepler Cheuvreux, *Morgan Stanley, Panmure Liberum, Peel Hunt LLP, Shore Capital, Stifel, *UBS.

*Corporate Brokers to British Land plc.

This analysis is a collation of forecasts which have been provided to us by registered investment analysts. British Land has not endorsed or commented on any individual forecasts, nor do we intend to do so in future. The circulation of the consensus does not provide or imply any check on, or endorsement of, the analysts' forecasts by British Land.

It should be noted that forecasts are by definition forward looking and are therefore subject to risks and uncertainties that may materially affect eventual results. Neither British Land nor any director, officer or employee of British Land accepts any responsibility for the accuracy of the forecasts used in this analysis and therefore shall have no liability whatsoever for the consequences of any reliance or actions taken or not taken based on any of the information in the analysis. Nothing in this analysis should be taken as a recommendation to buy or sell shares in British Land or to take any other action or place any reliance on the analysis.

Although we will endeavour to keep this information updated, we assume no obligation to update or revise such information to reflect circumstances existing after the date hereof.

For all queries regarding consensus, please contact our Investor Relations team.